Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it will receive CNY 500,000,000 in an equity round of funding on October 18, 2023. The transaction will include participation from new investor, ZhuZhou QianJin Pharmaceutical Co.,Ltd for CNY 50,000,000 for 1.5870% stake. Through the transaction, the company will increase its registered capital from CNY 480,494,941 to not more than CNY 57,114,034.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11.73 CNY | +1.56% | +3.44% | +8.91% |
1st Jan change | Capi. | |
---|---|---|
+8.91% | 685M | |
+30.78% | 662B | |
+21.96% | 546B | |
-5.19% | 359B | |
+16.98% | 323B | |
+4.88% | 289B | |
+13.68% | 234B | |
+3.81% | 198B | |
-10.63% | 194B | |
+4.10% | 167B |
- Stock Market
- Equities
- 600479 Stock
- News ZhuZhou QianJin Pharmaceutical Co.,Ltd
- Hunan Xinhexin Bio-Pharmaceutical Co., Ltd. announced that it expects to receive CNY 500 million in funding from ZhuZhou QianJin Pharmaceutical Co.,Ltd